Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 302 results
A retinal imaging device in a clinical setting, highlighting the focus on diabetic retinopathy screening.

May 29, 2026

AI-Driven Diabetic Retinopathy Screening Market is expected

The AI-driven diabetic retinopathy screening market is projected to experience significant growth, reaching an estimated value of $2.22 billion by 2033. This growth is fueled by a compound annual growth rate (CAGR) of 21% from 2026 to 2033, as the industry increasingly adopts AI technologies for early disease detection and diagnosis.The market encompasses various AI-based solutions that enhance the detection and diagnosis of diabetic retinopathy through advanced retinal imaging and automated ana
CT scanner in a dimly lit radiology room

May 29, 2026

AI-Powered Diagnostic Imaging Market Size, Share & Industry

The AI-powered diagnostic imaging market is on a significant growth trajectory, projected to reach USD 22.58 billion by 2032, expanding at a compound annual growth rate (CAGR) of 26.40% from 2026 to 2032.This expansion is fueled by a surge in demand for AI-assisted disease detection, advancements in imaging technologies, and increased investments in precision diagnostics. The integration of machine learning and computer vision into radiology is enhancing diagnostic accuracy and addressing the sh
X-ray film on a lightbox in a dimly lit radiology room

May 29, 2026

Teleradiology Market Surges as Remote Diagnostics and AI Transform Global Medical Imaging

The teleradiology market is experiencing significant growth, driven by advancements in remote diagnostics and artificial intelligence, transforming the landscape of medical imaging globally.Historically, radiology relied heavily on onsite professionals to interpret medical images such as X-rays and MRIs. However, the rise of digital communication technologies has enabled healthcare providers to transmit these images securely across vast distances, facilitating remote interpretation by expert rad
A minimalist illustration of a lung and a screening device in a dark palette.

May 29, 2026

Median Technologies: €40 Million Capital Increase Launched To Support eyonis LCS Expansion

Median Technologies has initiated a €40 million capital increase, potentially rising to €50 million, aimed at enhancing the commercial rollout of its AI-driven eyonis LCS lung cancer screening platform in the U.S. and Europe, while also expanding its capabilities to address additional cancer types.The capital increase will occur via a public offering of ordinary shares, with a reserved offering for guarantors amounting to €10 million contingent on full subscription. Median Technologies has alrea
A tissue slide in a dimly lit pathology lab, showcasing the PD-L1 biomarker analysis.

May 28, 2026

Leica Biosystems, Indica Labs, And Lunit Advance AI Powered Digital Pathology For PD L1 Biomarker Analysis

Leica Biosystems, Indica Labs, and Lunit are collaborating to enhance AI-driven digital pathology, specifically for PD-L1 biomarker analysis, aiming to streamline and standardize pathology workflows in precision oncology research.The partnership builds on an existing collaboration between Leica Biosystems and Indica Labs, now incorporating Lunit's advanced AI capabilities. This integration is set to enhance the quantification of PD-L1 and other immunohistochemistry biomarkers, providing a more c
Minimalist illustration of a prostate gland and biomarker icon

May 28, 2026

Myriad Genetics Inc stock (US62855J1043): Prolaris AI launch lifts focus

Myriad Genetics Inc. is generating renewed interest among investors following the announcement of its Prolaris + AI Test, set to launch this month. The stock was noted at $3.93, reflecting a 2.1% increase after the May 26 update.The Prolaris + AI Test represents a significant advancement in prostate cancer surveillance by integrating biomarker data with AI-driven pathology. This launch is particularly noteworthy as it positions Myriad Genetics within the competitive landscape of specialty diagno
A dual glucose-ketone sensor on a wooden table in a clinical setting.

May 28, 2026

Abbott Laboratories stock (US0028241000): regulatory clearances for AI cardiology and glucose-ketone

Abbott Laboratories has recently secured regulatory approvals for two significant digital health innovations: an AI-assisted coronary imaging platform and a dual glucose-ketone sensor, enhancing its portfolio in cardiology and diabetes care.The Ultreon 3.0 platform is designed to assist physicians during coronary stent procedures by integrating imaging and data-driven insights, while the Libre Duo sensor aims to provide comprehensive monitoring for diabetes patients by tracking both glucose and
A tissue sample on a microscope slide in a lab setting

May 28, 2026

Finnish researchers use AI to accelerate colorectal cancer diagnostics

Researchers at the University of Jyväskylä have developed an artificial intelligence model that significantly enhances the speed and accuracy of colorectal cancer diagnostics by analyzing tissue samples and predicting DNA repair mechanisms.This innovative approach addresses the traditionally time-consuming process of evaluating cancer samples, which can take several days in pathology laboratories. The AI model can reduce this analysis time to mere minutes, potentially leading to significant cost
A minimalist illustration of a brain and an MRI machine on a dark background.

May 28, 2026

Simulations + AI = faster brain MRI scans

Recent advancements in MRI technology are poised to significantly enhance brain imaging efficiency and accuracy. Researchers at the Institute for Neurosciences CSIC-UMH have developed a method that combines simulations with artificial intelligence to reduce the time needed for MRI scans, enabling the integration of more sophisticated imaging techniques.This innovative approach not only accelerates scan times but also mitigates biases typically found in traditional clinical datasets. By leveragin
A diagnostic test kit on a lab countertop with a petri dish in the background.

May 27, 2026

IDXX: AI-driven innovation and expanding diagnostics platforms are propelling strong growth and sector leadership

IDEXX Laboratories is experiencing notable growth, driven by a strategic focus on innovation and the integration of advanced diagnostics and software solutions. The company's new CEO is implementing a purpose-driven strategy that emphasizes global expansion and the development of integrated diagnostic platforms. Key innovations such as inVue Dx and Cancer Dx are enhancing IDEXX's market position, showcasing strong adoption and expanding capabilities within the diagnostics sector. With a promisin
A minimalist representation of a microscope lens in flat design.

May 27, 2026

NIT Rourkela Develops AI-Enabled Autofocusing Technology for Microscopic Imaging

Researchers at NIT Rourkela have unveiled an innovative AI-enabled autofocusing technology aimed at enhancing microscopic imaging for biomedical diagnostics. This development, in partnership with Glowvista Instruments, addresses key challenges faced by traditional microscopy systems, such as manual focus adjustments that can lead to diagnostic inaccuracies and delays.The newly patented technology, titled “A Method for Autofocusing in Optofluidic Microsystems and Processes,” integrates deep learn
An MRI machine in a dimly lit hospital imaging room with a patient on the table.

May 27, 2026

Diagnostic Imaging Market Expected to Reach US$68.81 Billion by 2034 as AI-Powered Technologies Transform Healthcare Diagnostics

The diagnostic imaging market is on track to reach approximately US$68.81 billion by 2034, driven by advancements in AI and increasing healthcare demands.As chronic illnesses rise and the emphasis on preventive care intensifies, diagnostic imaging has become crucial in clinical decision-making. Various imaging technologies, such as X-rays, MRIs, and CT scans, enable healthcare professionals to accurately visualize internal structures, facilitating early disease detection and better patient outco